| Biologically Active Taxane Analogs and Methods of Treatment by Oral … |
2021-12-01 |
2022-3-24 |
|
| Taxane Analogs for the Treatment of Brain Cancer |
2021-9-09 |
2021-12-30 |
|
| Biologically Active Taxane Analogs and Methods of Treatment by Oral … |
2020-7-15 |
2020-11-05 |
|
| 9,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof |
2020-4-15 |
2020-7-30 |
|
| Taxane Analogs for the Treatment of Brain Cancer |
2018-10-12 |
2019-2-14 |
|
| Decorative components and the method for being used to form the decorative … |
2015-1-08 |
2019-1-18 |
2019-1-18 |
| Taxane analogues, their use, pharmaceutical compositions containing them, and … |
2010-8-25 |
2011-3-10 |
|
| Molecular conjugate for use in treatment of cancer |
2010-4-19 |
2010-11-11 |
|
| Biologically active taxane analogs and methods of treatment |
2010-4-09 |
2011-1-13 |
|
| A convergent process for the synthesis of taxane derivatives |
2007-3-27 |
2008-3-01 |
|
| Processes for taxane derivatives and intermediates useful therein. |
2006-12-21 |
2008-9-24 |
|
| Processes for taxane derivatives and intermediates useful therein |
2006-12-21 |
2009-3-04 |
|
| Molecular constructs suitable for targeted conjugates |
2006-5-11 |
2006-11-23 |
|
| Therapeutic regimen for treating cancer using quassinoids and other … |
2005-9-26 |
2009-5-28 |
|
| Quassinoid compositions for the treatment of cancer and other proliferative … |
2005-6-13 |
2006-12-14 |
|
| Mammalian cell lines for detecting, monitoring, and optimizing oligonucleotide- … |
2004-11-10 |
2005-6-02 |
|
| 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof |
2004-9-27 |
2008-4-30 |
|
| Methods for production of non-disease causing hemoglobin by ex vivo … |
2004-4-30 |
2005-2-03 |
|
| Methods and compositions for reducing screening in oligonucleotide-directed … |
2003-10-07 |
2004-5-04 |
|
| Etticient process for production of 10-DAB III by selective hydrazinolysis of … |
2002-7-02 |
2004-10-20 |
|
| Chiral resolution method for producing compounds useful in the synthesis of … |
2002-6-27 |
2004-4-28 |
|
| Chiral resolution method for producing compounds useful in the synthesis of … |
2002-6-27 |
2003-3-03 |
|
| Two-step conversion of protected taxane ester to paclitaxel |
2002-4-25 |
2002-10-31 |
|
| Three-step conversion of protected taxane ester to paclitaxel |
2002-4-25 |
2002-10-31 |
|
| Molecular conjugates for use in treatment of cancer |
2002-3-25 |
2003-3-27 |
|
| Synthesis of epothilones and related analogs |
2001-10-15 |
2002-7-11 |
|
| Enhanced targeting of dna sequences by recombinase protein and single-stranded … |
2001-7-31 |
2002-2-07 |
|
| Stable isotope labeling of paclitaxel |
2001-6-07 |
2001-12-13 |
|
| Paclitaxel treatment regimen for metastatic melanoma |
2001-4-18 |
2002-1-31 |
|
| Simple and efficient hydrazinolysis of c-10 and c-13 ester functionalities of … |
2001-3-16 |
2001-9-24 |
|
| Integrated genomic services |
2001-2-12 |
2002-3-14 |
|